FDA cleared the PulseAPI SmartWatch from PulseAI, Ltd. on Oct 27, 2026 under K254226, a traditional 510(k). The device falls under product code DQK, Computer, Diagnostic, Programmable, regulated at 21 CFR 870.1425 as a Class 2 device. The review panel was Cardiovascular.

FDA logged the submission as received on Dec 29, 2025. The decision came 302 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.

This is the only decision on file for PulseAI, Ltd. in the last 12 months of the tracker.